Trinity Biotech Announces Strategic Partnership with imaware™

Trinity Biotech announces imaware Partnership

Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference

Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference

Trinity Biotech Attends Medica 2022

Today members of Trinity Biotech sales team attended Medica 2022.

Daniella Badea (Regional Sales Manager), Dearbhla Kane (Sales Representative Fitzgerald), Chris Sykes (Executive Vice President Fitzgerald), Nick O’Hare (Vice President of International Sales), Kevin Lillis (Global Product Manager Autoimmunity) and Tamires Gimenez (Global Product Manager Haemoglobins) attended the conference representing the Company.

Veterans Day

No alternative text description for this image

Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO

Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO

Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test

Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test

Trinity Biotech Announces The Successful Closing of its Strategic Investment And Partnership With The MiCo Group of South Korea

Trinity Biotech Announces The Successful Closing of its Strategic Investment And Partnership With The MiCo Group of South Korea

Trinity Biotech announces Quarter 4 and Fiscal Year 2021 Financial Results

Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea

Trinity Biotech Announces the World Health Organistion Approval Of TrinScreen™ HIV

Trinity Biotech Announces the World Health Organistion Approval Of TrinScreen™ HIV

Trinity Biotech Announces The Successful Closing of its Debt Refinancing

Trinity Biotech Announces The Successful Closing of its Debt Refinancing

Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of the EGM Held on January 25, 2022

Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of the EGM Held on January 25, 2022

Trinity Biotech Announces Q3 2021 Financial Results

Trinity Biotech Announces Q3 2021 Financial Results

Trinity Biotech Provides A Business Development Update For Q2 2021

Trinity Biotech Provides A Business Development Update For Q2 2021

Trinity Biotech Announces Q3 2019 Financial Results

Trinity Biotech Announces Q3 2019 Financial Results

Trinity Biotech plc to Announce Third Quarter Fiscal Year 2019 Results

Trinity Biotech plc to Announce Third Quarter Fiscal Year 2019 Results